DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Cancer Drug Market

Global Cancer Drug Market Opportunities and Forecast 2020-2027

  • DLR2523
  • 17 August, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Cancer Drug Market, By Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy), By Indication (Lung Cancer, Stomach Cancer, Breast Cancer, Prostate Cancer, Others), End-user (Hospitals, Clinics, Others), and opportunities and forecast 2020-2027

Cancer Drug Market Overview

Cancer is a disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body. The whole medical research fraternity has prioritized cancer research to find new ways of treatment and analysis. Cancer drugs are used in the treatment of breast cancer, ovarian cancer, pancreatic cancer, kidney cancer, brain tumors, gastric cancer, and other cancers through chemotherapy, surgery, and radiotherapy.

In current times, several regions have occurred as hubs of cancer research, drug development, and medical testing. This key factor has been fuelling the growth of the global Cancer Drug market. Moreover, other factors such as cancer research entities are involved in the development of drugs that directly target cancer cells. This crucial factor primally boosting the growth of the global Cancer Drugs market. Besides, the large focus on biological therapy also enhanced the growth of the global Cancer Drugs market over the last few years.

Additionally, the tremendous efforts of the World Health Organization in promoting cancer research and drug development have also played an important role in boosting the growth of the market. According to World Health Organization, cancer is the second leading cause of death globally, accounting for an estimated 9.6 million deaths, or one in six deaths, in 2018. Lung, prostate, colorectal, stomach, and liver cancer are the most common types of cancer in men, while breast, colorectal, lung, cervical, and thyroid cancer are the most common among women.

On the downside, the high cost of new drug development, combined with the risk of failure and side-effects related to cancer drug therapies, is anticipated to hamper the growth of the Cancer Drugs market. Furthermore, the pursuit of oncologists to find appropriate and correct treatments has also propelled the growth of the market. In addition to this, all forms of cancer drugs introduced are quick to be tested, which further influenced the market’s growth progressively.

Covid-19 Impact on Cancer Drug Market

In addition, the current Cancer Drug Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Cancer Drug Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Cancer Drug Market Segment Overview

Based on Drug Class Type, the Targeted Therapy segment accounted for the largest share in the Cancer Drug market. This can be mainly attributed to the identification of molecular targets of cancer cells. Recent developments in cellular technology and gene therapy have contributed to improving the understanding of tumor cells and their metabolism at the molecular level, hence driving the need for targeted drug therapies for cancer treatment.

According to Indication, the Breast Cancer segment has significant growth in the market. As per data by World Health Organization, in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years, making it the world’s most dominant cancer. In addition, there are more lost disability-adjusted life years by women to breast cancer globally than any other type of cancer. Breast cancer occurs in every country of the world in women at any age after puberty but with increasing rates in later life.  

Cancer Drug Market, By Drug Class Type

·       Chemotherapy
·       Targeted Therapy
·       Immunotherapy
·       Hormonal Therapy

Cancer Drug Market, By Indication

·       Lung Cancer
·       Stomach Cancer
·       Breast Cancer
·       Prostate Cancer
·       Others

Cancer Drug Market, End-User

·       Hospitals
·       Clinics
·       Others

Cancer Drug Market Regional Overview

Region-wise, North America is expected to account for a maximum share of the global Cancer Drugs market and it maintains its supremacy throughout the forecast period. This can be primarily attributed to the presence of well-developed institutes for cancer research and treatment in this region. Moreover, the cancer drugs market in the Asia Pacific is projected to enlarge at a rapid pace in the forecast period. Major factors such as increasing expenditure on healthcare, rising disposable income, increasing research & development activities, coupled with growing awareness associated with different types of cancers significantly contribute to the development of the market in this region.

Cancer Drug Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Cancer Drug Market Competitor overview

Some key developments and strategies adopted by manufacturers in Cancer Drug are highlighted below.

In August 2021, InxMed (Nanjing) Co., Ltd., a clinical-stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to IN10018 for the treatment of platinum-resistant ovarian cancer patients. InxMed owns the global patent and development right of IN10018. The Fast-Track designation for IN10018 underscores the urgent need for new treatment options for platinum-resistant ovarian cancer patients and the significant treatment potential of IN10018, it also further proves the InxMed's world-class translational and clinical development capabilities.

Cancer Drug Market, Key Players

·       F. Hoffmann-La Roche AG
·       Novartis AG
·       Bristol-Myers Squibb Company
·       Merck & Co., Inc.
·       Johnson & Johnson
·       AbbVie Inc.
·       Amgen
·       Astellas Pharma Inc.
·       AstraZeneca PLC
·       Pfizer Inc.

Cancer Drug Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Cancer Drug Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Drug Class Type
        • 5.2.1. Chemotherapy
        • 5.2.2. Targeted Therapy
        • 5.2.3. Immunotherapy
        • 5.2.4. Hormonal Therapy
      • 5.3. Market Analysis, Insights and Forecast – By Indication
        • 5.3.1. Lung Cancer
        • 5.3.2. Stomach Cancer
        • 5.3.3. Breast Cancer
        • 5.3.4. Prostate Cancer
        • 5.3.5. Others
      • 5.4. Market Analysis, Insights and Forecast – By End-User
        • 5.4.1. Hospitals
        • 5.4.2. Clinics
        • 5.4.3. Others
      • 5.5. Market Analysis, Insights and Forecast – By Region
        • 5.5.1. North America
        • 5.5.2. Europe
        • 5.5.3. Asia Pacific
        • 5.5.4. Latin America, Middle East and Africa

      6. North America Cancer Drug Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Drug Class Type
        • 6.2.1. Chemotherapy
        • 6.2.2. Targeted Therapy
        • 6.2.3. Immunotherapy
        • 6.2.4. Hormonal Therapy
      • 6.3. Market Analysis, Insights and Forecast – By Indication
        • 6.3.1. Lung Cancer
        • 6.3.2. Stomach Cancer
        • 6.3.3. Breast Cancer
        • 6.3.4. Prostate Cancer
        • 6.3.5. Others
      • 6.4. Market Analysis, Insights and Forecast – By End-User
        • 6.4.1. Hospitals
        • 6.4.2. Clinics
        • 6.4.3. Others
      • 6.5. Market Analysis, Insights and Forecast – By Country
        • 6.5.1. U.S.
        • 6.5.2. Canada

      7. Europe Cancer Drug Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Drug Class Type
        • 7.2.1. Chemotherapy
        • 7.2.2. Targeted Therapy
        • 7.2.3. Immunotherapy
        • 7.2.4. Hormonal Therapy
      • 7.3. Market Analysis, Insights and Forecast – By Indication
        • 7.3.1. Lung Cancer
        • 7.3.2. Stomach Cancer
        • 7.3.3. Breast Cancer
        • 7.3.4. Prostate Cancer
        • 7.3.5. Others
      • 7.4. Market Analysis, Insights and Forecast – By End-User
        • 7.4.1. Hospitals
        • 7.4.2. Clinics
        • 7.4.3. Others
      • 7.5. Market Analysis, Insights and Forecast – By Country
        • 7.5.1. UK
        • 7.5.2. Germany
        • 7.5.3. France
        • 7.5.4. Italy
        • 7.5.5. Spain
        • 7.5.6. Russia
        • 7.5.7. Rest of Europe

      8. Asia Pacific Cancer Drug Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Drug Class Type
        • 8.2.1. Chemotherapy
        • 8.2.2. Targeted Therapy
        • 8.2.3. Immunotherapy
        • 8.2.4. Hormonal Therapy
      • 8.3. Market Analysis, Insights and Forecast – By Indication
        • 8.3.1. Lung Cancer
        • 8.3.2. Stomach Cancer
        • 8.3.3. Breast Cancer
        • 8.3.4. Prostate Cancer
        • 8.3.5. Others
      • 8.4. Market Analysis, Insights and Forecast – By End-User
        • 8.4.1. Hospitals
        • 8.4.2. Clinics
        • 8.4.3. Others
      • 8.5. Market Analysis, Insights and Forecast – By Country
        • 8.5.1. China
        • 8.5.2. India
        • 8.5.3. Japan
        • 8.5.4. Australia
        • 8.5.5. South East Asia
        • 8.5.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa Cancer Drug Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Drug Class Type
        • 9.2.1. Chemotherapy
        • 9.2.2. Targeted Therapy
        • 9.2.3. Immunotherapy
        • 9.2.4. Hormonal Therapy
      • 9.3. Market Analysis, Insights and Forecast – By Indication
        • 9.3.1. Lung Cancer
        • 9.3.2. Stomach Cancer
        • 9.3.3. Breast Cancer
        • 9.3.4. Prostate Cancer
        • 9.3.5. Others
      • 9.4. Market Analysis, Insights and Forecast – By End-User
        • 9.4.1. Hospitals
        • 9.4.2. Clinics
        • 9.4.3. Others
      • 9.5. Market Analysis, Insights and Forecast – By Country
        • 9.5.1. Brazil
        • 9.5.2. Saudi Arabia
        • 9.5.3. UAE
        • 9.5.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. F. Hoffmann-La Roche AG
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Novartis AG
      • 10.6. Bristol-Myers Squibb Company
      • 10.7. Merck & Co., Inc.
      • 10.8. Johnson & Johnson
      • 10.9. AbbVie Inc.
      • 10.10. Amgen
      • 10.11. Astellas Pharma Inc.
      • 10.12. AstraZeneca PLC
      List of Figures

      Figure 1: Global Cancer Drug Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Cancer Drug Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Cancer Drug Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Cancer Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global Cancer Drug Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Cancer Drug Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Cancer Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Cancer Drug Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Cancer Drug Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America Cancer Drug Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Cancer Drug Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Cancer Drug Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Cancer Drug Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Cancer Drug Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Cancer Drug Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Cancer Drug Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America Cancer Drug Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Cancer Drug Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Cancer Drug Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Cancer Drug Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Cancer Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Cancer Drug Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Cancer Drug Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Cancer Drug Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Cancer Drug Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe Cancer Drug Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Cancer Drug Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Cancer Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Cancer Drug Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Cancer Drug Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Cancer Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Cancer Drug Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Cancer Drug Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Cancer Drug Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Cancer Drug Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Cancer Drug Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Cancer Drug Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Cancer Drug Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Cancer Drug Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific Cancer Drug Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Cancer Drug Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Cancer Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Cancer Drug Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Cancer Drug Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Cancer Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Cancer Drug Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Cancer Drug Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Cancer Drug Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Cancer Drug Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Cancer Drug Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Cancer Drug Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Cancer Drug Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa Cancer Drug Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Cancer Drug Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Cancer Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Cancer Drug Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Cancer Drug Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Cancer Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Cancer Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Cancer Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Cancer Drug Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Cancer Drug Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Cancer Drug Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Cancer Drug Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Cancer Drug Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Cancer Drug Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Cancer Drug Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Cancer Drug Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Cancer Drug Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Cancer Drug Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Cancer Drug Market Revenue (USD Billion) Forecast, by Country, 2016-2027

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934